Viral infection prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid dendritic cell interplay

Journal of Experimental Medicine

Volumn 208, Issue 4, 2011, Pages 729-745

  Diana, Julien ^a,b   Brezar, Vedran ^a,b   Beaudoin, Lucie ^a,b   Dalod, Marc ^c,d,e   Mellor, Andrew ^f   Tafuri, Anna ^d   von Herrath, Matthias ^g   Boitard, Christian ^a,b   Mallone, Roberto ^a,b   Lehuen, Agnès ^a,b  

^a université Paris Cité   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^d INSERM   (France)

^e CNRS   (France)

^f MEDICAL COLLEGE OF GEORGIA   (United States)

^g LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DIABETES MELLITUS; INSULIN DEPENDENT DIABETES MELLITUS; LYMPH NODE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; VIRUS INFECTION;

EID: 79955738789     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20101692     Document Type: Article

References (68)

1. Alyanakian, M.A., F. Grela, A. Aumeunier, C. Chiavaroli, C. Gouarin, E. Bardel, G. Normier, L. Chatenoud, N. Thieblemont, and J.F. Bach. 2006. Transforming growth factor-beta and natural killer T-cells are involved in the protective effect of a bacterial extract on type 1 diabetes. Diabetes. 55:179-185.
2. Anderson, M.S., and J.A. Bluestone. 2005. The NOD mouse: a model of immune dysregulation. Annu. Rev. Immunol. 23:447-485.
3. Asselin-Paturel, C., G. Brizard, J.J. Pin, F. Brière, and G. Trinchieri. 2003. Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody. J. Immunol. 171:6466-6477.
4. Barber, D.L., E.J. Wherry, D. Masopust, B. Zhu, J.P. Allison, A.H. Sharpe, G.J. Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 439:682-687.
5. Beaudoin, L., V. Laloux, J. Novak, B. Lucas, and A. Lehuen. 2002. NKT cells inhibit the onset of diabetes by impairing the development of pathogenic T cells specific for pancreatic beta cells. Immunity. 17:725-736.
6. Belkaid, Y., and G. Oldenhove. 2008. Tuning microenvironments: induction of regulatory T cells by dendritic cells. Immunity. 29:362-371.
7. Belkaid, Y., and K. Tarbell. 2009. Regulatory T cells in the control of hostmicroorganism interactions. Annu. Rev. Immunol. 27:551-589.
8. Bendelac, A., P.B. Savage, and L. Teyton. 2007. The biology of NKT cells. Annu. Rev. Immunol. 25:297-336.
9. Brooks, D.G., S.J. Ha, H. Elsaesser, A.H. Sharpe, G.J. Freeman, and M.B. Oldstone. 2008. IL-10 and PD-L1 operate through distinct pathways to suppress T-cell activity during persistent viral infection. Proc. Natl. Acad. Sci. USA. 105:20428-20433.
10. Chen, Y.G., C.M. Choisy-Rossi, T.M. Holl, H.D. Chapman, G.S. Besra, S.A. Porcelli, D.J. Shaffer, D. Roopenian, S.B. Wilson, and D.V. Serreze. 2005a. Activated NKT cells inhibit autoimmune diabetes through tolerogenic recruitment of dendritic cells to pancreatic lymph nodes. J. Immunol. 174:1196-1204.
11. Chen, Z., A.E. Herman, M. Matos, D. Mathis, and C. Benoist. 2005b. Where CD4+CD25+ T reg cells impinge on autoimmune diabetes. J. Exp. Med. 202:1387-1397.
12. Diana, J., and A. Lehuen. 2009. NKT cells: friend or foe during viral infections? Eur. J. Immunol. 39:3283-3291.
13. Diana, J., T. Griseri, S. Lagaye, L. Beaudoin, E. Autrusseau, A.S. Gautron, C. Tomkiewicz, A. Herbelin, R. Barouki, M. von Herrath, et al. 2009. NKT cell-plasmacytoid dendritic cell cooperation via OX40 controls viral infection in a tissue-specific manner. Immunity. 30:289-299.
14. Dotta, F., S. Censini, A.G. van Halteren, L. Marselli, M. Masini, S. Dionisi, F. Mosca, U. Boggi, A.O. Muda, S.D. Prato, et al. 2007. Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients. Proc. Natl. Acad. Sci. USA. 104:5115-5120.
15. Fallarino, F., U. Grohmann, K.W. Hwang, C. Orabona, C. Vacca, R. Bianchi, M.L. Belladonna, M.C. Fioretti, M.L. Alegre, and P. Puccetti. 2003. Modulation of tryptophan catabolism by regulatory T cells. Nat. Immunol. 4:1206-1212.
16. Feuerer, M., Y. Shen, D.R. Littman, C. Benoist, and D. Mathis. 2009. How punctual ablation of regulatory T cells unleashes an autoimmune lesion within the pancreatic islets. Immunity. 31:654-664.
17. Filippi, C.M., and M.G. von Herrath. 2008. Viral trigger for type 1 diabetes: pros and cons. Diabetes. 57:2863-2871.
18. Filippi, C.M., E.A. Estes, J.E. Oldham, and M.G. von Herrath. 2009. Immunoregulatory mechanisms triggered by viral infections protect from type 1 diabetes in mice. J. Clin. Invest. 119:1515-1523.
19. Fontenot, J.D., J.P. Rasmussen, L.M. Williams, J.L. Dooley, A.G. Farr, and A.Y. Rudensky. 2005. Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity. 22:329-341.
20. Francisco, L.M., V.H. Salinas, K.E. Brown, V.K. Vanguri, G.J. Freeman, V.K. Kuchroo, and A.H. Sharpe. 2009. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J. Exp. Med. 206:3015-3029.
21. Green, E.A., L. Gorelik, C.M. McGregor, E.H. Tran, and R.A. Flavell. 2003. CD4+CD25+ T regulatory cells control anti-islet CD8+ T cells through TGF-beta-TGF-beta receptor interactions in type 1 diabetes. Proc. Natl. Acad. Sci. USA. 100:10878-10883.
22. Hadeiba, H., T. Sato, A. Habtezion, C. Oderup, J. Pan, and E.C. Butcher. 2008. CCR9 expression defines tolerogenic plasmacytoid dendritic cells able to suppress acute graft-versus-host disease. Nat. Immunol. 9:1253-1260.
23. Herman, A.E., G.J. Freeman, D. Mathis, and C. Benoist. 2004. CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion. J. Exp. Med. 199:1479-1489.
24. Horwitz, M.S., L.M. Bradley, J. Harbertson, T. Krahl, J. Lee, and N. Sarvetnick. 1998. Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat. Med. 4:781-785.
25. Irla, M., N. Küpfer, T. Suter, R. Lissilaa, M. Benkhoucha, J. Skupsky, P.H. Lalive, A. Fontana, W. Reith, and S. Hugues. 2010. MHC class II-restricted antigen presentation by plasmacytoid dendritic cells inhibits T cell-mediated autoimmunity. J. Exp. Med. 207:1891-1905.
26. Ito, T., M. Yang, Y.H. Wang, R. Lande, J. Gregorio, O.A. Perng, X.F. Qin, Y.J. Liu, and M. Gilliet. 2007. Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J. Exp. Med. 204:105-115.
27. Judkowski, V., C. Pinilla, K. Schroder, L. Tucker, N. Sarvetnick, and D.B. Wilson. 2001. Identification of MHC class II-restricted peptide ligands, including a glutamic acid decarboxylase 65 sequence, that stimulate diabetogenic T cells from transgenic BDC2.5 nonobese diabetic mice. J. Immunol. 166:908-917.
28. Kang, H.K., M. Liu, and S.K. Datta. 2007. Low-dose peptide tolerance therapy of lupus generates plasmacytoid dendritic cells that cause expansion of autoantigen-specific regulatory T cells and contraction of inflammatory Th17 cells. J. Immunol. 178:7849-7858.
29. Kared, H., A. Masson, H. Adle-Biassette, J.F. Bach, L. Chatenoud, and F. Zavala. 2005. Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4(+)CD25(+) regulatory T-cells. Diabetes. 54:78-84.
30. Keir, M.E., M.J. Butte, G.J. Freeman, and A.H. Sharpe. 2008. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26:677-704.
31. Kent, S.C., Y. Chen, S.M. Clemmings, V. Viglietta, N.S. Kenyon, C. Ricordi, B. Hering, and D.A. Hafler. 2005. Loss of IL-4 secretion from human type 1a diabetic pancreatic draining lymph node NKT cells. J. Immunol. 175:4458-4464.
32. Knip, M., R. Veijola, S.M. Virtanen, H. Hyöty, O. Vaarala, and H.K. Akerblom. 2005. Environmental triggers and determinants of type 1 diabetes. Diabetes. 54:S125-S136.
33. Kohm, A.P., J.S. McMahon, J.R. Podojil, W.S. Begolka, M. DeGutes, D.J. Kasprowicz, S.F. Ziegler, and S.D. Miller. 2006. Cutting Edge: Anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells. J. Immunol. 176:3301-3305.
34. Kretschmer, K., I. Apostolou, D. Hawiger, K. Khazaie, M.C. Nussenzweig, and H. von Boehmer. 2005. Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol. 6:1219-1227.
35. Kuipers, H., F. Muskens, M. Willart, D. Hijdra, F.B. van Assema, A.J. Coyle, H.C. Hoogsteden, and B.N. Lambrecht. 2006. Contribution of the PD-1 ligands/PD-1 signaling pathway to dendritic cell-mediated CD4+ T cell activation. Eur. J. Immunol. 36:2472-2482.
36. Laloux, V., L. Beaudoin, D. Jeske, C. Carnaud, and A. Lehuen. 2001. NK T cell-induced protection against diabetes in V alpha 14-J alpha 281 transgenic nonobese diabetic mice is associated with a Th2 shift circumscribed regionally to the islets and functionally to islet autoantigen. J. Immunol. 166:3749-3756.
37. Lee, P.T., A. Putnam, K. Benlagha, L. Teyton, P.A. Gottlieb, and A. Bendelac. 2002. Testing the NKT cell hypothesis of human IDDM pathogenesis. J. Clin. Invest. 110:793-800.
38. Lehuen, A., O. Lantz, L. Beaudoin, V. Laloux, C. Carnaud, A. Bendelac, J.F. Bach, and R.C. Monteiro. 1998. Overexpression of natural killer T cells protects Vα14- Jα281 transgenic nonobese diabetic mice against diabetes. J. Exp. Med. 188:1831-1839.
39. Lehuen, A., J. Diana, P. Zaccone, and A. Cooke. 2010. Immune cell crosstalk in type 1 diabetes. Nat. Rev. Immunol. 10:501-513.
40. Li, M.O., and R.A. Flavell. 2008. Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. Immunity. 28:468-476.
41. Martín-Gayo, E., E. Sierra-Filardi, A.L. Corbí, and M.L. Toribio. 2010. Plasmacytoid dendritic cells resident in human thymus drive natural Treg cell development. Blood. 115:5366-5375.
42. Martinic, M.M., A.E. Juedes, D. Bresson, D. Homann, K. Skak, C. Huber, E. Ling, M. Ejrnaes, T. Wolfe, L. Togher, et al. 2007. Minimal impact of a de novo-expressed beta-cell autoantigen on spontaneous diabetes development in NOD mice. Diabetes. 56:1059-1068.
43. Mathis, D., L. Vence, and C. Benoist. 2001. beta-Cell death during progression to diabetes. Nature. 414:792-798.
44. Mendiratta, S.K., W.D. Martin, S. Hong, A. Boesteanu, S. Joyce, and L. Van Kaer. 1997. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4. Immunity. 6:469-477.
45. Monteiro, M., C.F. Almeida, M. Caridade, J.C. Ribot, J. Duarte, A. Agua-Doce, I. Wollenberg, B. Silva-Santos, and L. Graca. 2010. Identification of regulatory Foxp3+ invariant NKT cells induced by TGF-beta. J. Immunol. 185:2157-2163.
46. Naumov, Y.N., K.S. Bahjat, R. Gausling, R. Abraham, M.A. Exley, Y. Koezuka, S.B. Balk, J.L. Strominger, M. Clare-Salzer, and S.B. Wilson. 2001. Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc. Natl. Acad. Sci. USA. 98:13838-13843.
47. Nejentsev, S., N. Walker, D. Riches, M. Egholm, and J.A. Todd. 2009. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science. 324:387-389.
48. Nishio, J., M. Feuerer, J. Wong, D. Mathis, and C. Benoist. 2010. Anti-CD3 therapy permits regulatory T cells to surmount T cell receptor-specified peripheral niche constraints. J. Exp. Med. 207:1879-1889.
49. Novak, J., L. Beaudoin, S. Park, T. Griseri, L. Teyton, A. Bendelac, and A. Lehuen. 2007a. Prevention of type 1 diabetes by invariant NKT cells is independent of peripheral CD1d expression. J. Immunol. 178:1332-1340.
50. Novak, J., T. Griseri, L. Beaudoin, and A. Lehuen. 2007b. Regulation of type 1 diabetes by NKT cells. Int. Rev. Immunol. 26:49-72.
51. Ochando, J.C., C. Homma, Y. Yang, A. Hidalgo, A. Garin, F. Tacke, V. Angeli, Y. Li, P. Boros, Y. Ding, et al. 2006. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat. Immunol. 7:652-662.
52. Oldstone, M.B. 1988. Prevention of type I diabetes in nonobese diabetic mice by virus infection. Science. 239:500-502.
53. Peng, Y., Y. Laouar, M.O. Li, E.A. Green, and R.A. Flavell. 2004. TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes. Proc. Natl. Acad. Sci. USA. 101:4572-4577.
54. Roep, B.O., H.S. Hiemstra, N.C. Schloot, R.R. De Vries, A. Chaudhuri, P.O. Behan, and J.W. Drijfhout. 2002. Molecular mimicry in type 1 diabetes: immune cross-reactivity between islet autoantigen and human cytomegalovirus but not Coxsackie virus. Ann. N. Y. Acad. Sci. 958:163-165.
55. Sharif, S., G.A. Arreaza, P. Zucker, Q.S. Mi, J. Sondhi, O.V. Naidenko, M. Kronenberg, Y. Koezuka, T.L. Delovitch, J.M. Gombert, et al. 2001. Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes. Nat. Med. 7:1057-1062.
56. Sharma, M.D., B. Baban, P. Chandler, D.Y. Hou, N. Singh, H. Yagita, M. Azuma, B.R. Blazar, A.L. Mellor, and D.H. Munn. 2007. Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2,3-dioxygenase. J. Clin. Invest. 117:2570-2582.
57. Tang, Q., and J.A. Bluestone. 2008. The Foxp3+ regulatory T cell: a jack of all trades, master of regulation. Nat. Immunol. 9:239-244.
58. Tang, Q., J.Y. Adams, C. Penaranda, K. Melli, E. Piaggio, E. Sgouroudis, C.A. Piccirillo, B.L. Salomon, and J.A. Bluestone. 2008. Central role of defective interleukin-2 production in the triggering of islet autoimmune destruction. Immunity. 28:687-697.
59. Thébault-Baumont, K., D. Dubois-Laforgue, P. Krief, J.P. Briand, P. Halbout, K. Vallon-Geoffroy, J. Morin, V. Laloux, A. Lehuen, J.C. Carel, et al. 2003. Acceleration of type 1 diabetes mellitus in proinsulin 2-deficient NOD mice. J. Clin. Invest. 111:851-857.
60. Tracy, S., K.M. Drescher, N.M. Chapman, K.S. Kim, S.D. Carson, S. Pirruccello, P.H. Lane, J.R. Romero, and J.S. Leser. 2002. Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence. J. Virol. 76:12097-12111.
61. Tracy, S., K.M. Drescher, J.D. Jackson, K. Kim, and K. Kono. 2010. Enteroviruses, type 1 diabetes and hygiene: a complex relationship. Rev. Med. Virol. 20:106-116.
62. Tupin, E., Y. Kinjo, and M. Kronenberg. 2007. The unique role of natural killer T cells in the response to microorganisms. Nat. Rev. Microbiol. 5:405-417.
63. Van Kaer, L. 2005. alpha-Galactosylceramide therapy for autoimmune diseases: prospects and obstacles. Nat. Rev. Immunol. 5:31-42.
64. Viskari, H., J. Ludvigsson, R. Uibo, L. Salur, D. Marciulionyte, R. Hermann, G. Soltesz, M. Füchtenbusch, A.G. Ziegler, A. Kondrashova, et al. 2005. Relationship between the incidence of type 1 diabetes and maternal enterovirus antibodies: time trends and geographical variation. Diabetologia. 48:1280-1287.
65. von Herrath, M.G., R.S. Fujinami, and J.L. Whitton. 2003. Microorganisms and autoimmunity: making the barren field fertile? Nat. Rev. Microbiol. 1:151-157.
66. Wilson, S.B., S.C. Kent, K.T. Patton, T. Orban, R.A. Jackson, M. Exley, S. Porcelli, D.A. Schatz, M.A. Atkinson, S.P. Balk, et al. 1998. Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. Nature. 391:177-181.
67. You, S., N. Thieblemont, M.A. Alyanakian, J.F. Bach, and L. Chatenoud. 2006. Transforming growth factor-beta and T-cell-mediated immunoregulation in the control of autoimmune diabetes. Immunol. Rev. 212:185-202.
68. Zaccone, P., O.T. Burton, and A. Cooke. 2008. Interplay of parasite-driven immune responses and autoimmunity. Trends Parasitol. 24:35-42.